|
Baseline
|
4-weeks
|
12-weeks
|
18-weeks
|
24-weeks
|
p value
|
---|
Primary Outcome Measure
|
FIQ
|
59.26a
|
37.16b
|
40.36b
|
42.04b
|
43.95b
|
0.006
|
Secondary Outcome Measures
|
PVAQ
|
40.57a
|
32.71b
|
26.71b
|
26.71b
|
26.57b
|
0.003
|
PCS
|
20.84a
|
10.43b
|
8.86b
|
8.29b
|
10..28b
|
0.006
|
NRS
|
Overall Quality of Life
|
3.14a
|
6.00b
|
6.14b
|
6.00b
|
5.00b
|
0.01
|
Overall Fibromyalgia Pain
|
7.00a
|
4.00b
|
4.29b
|
4.42b
|
4.85b
|
0.001
|
Overall Bone and Joint Pain
|
8.00a
|
4.14b
|
5.14b
|
4.86b
|
5.14b
|
0.004
|
Overall Non-Specified Pain
|
5.57a
|
4.00a,b
|
3.28b
|
3.42b
|
3.87b
|
0.033
|
- a, b indicate that they are significantly different